The observed decrease in albumin levels in SLE patients aligns with the findings of previous research, confirming the utility of albumin as a marker of disease activity and implying that patients with SLE in this study were likely in an active stage at the time of FDG PET/CT examinations. Here, ALB is linked to systemic lupus erythematosus.